Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway
Preprint
- 3 September 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Extracellular matrix (ECM) stiffening is a biophysical hallmark of solid tumors. Cutaneous melanoma is an aggressive malignancy characterized by high heterogeneity and phenotypic plasticity in which melanoma cells switch from a proliferative and differentiated phenotype to an invasive, dedifferentiated and therapy-resistant state. The impact of ECM stiffness on the diverse cellular phenotypes of melanoma remains poorly defined. Here, we show that melanoma cell subpopulations differ in their responses to mechanical signals. Compared to melanocytic cells, dedifferentiated cells exhibited increased proliferation, migration, and resistance to MAP kinase-targeted therapy when seeded on stiff collagen. In contrast, a soft ECM impaired their proliferation and migration, and sensitized them to targeted therapy. The mechanosensitivity of dedifferentiated cells relies on collagen receptors DDR1 and DDR2, which control cytoskeleton reorganization and YAP mechanosignaling. Our results thus reveal that phenotypic plasticity endows dedifferentiated melanoma cells with increased addiction to ECM stiffness and implicate DDR1/2-YAP-dependent signaling in this aggressive behavior.Keywords
All Related Versions
This publication has 60 references indexed in Scilit:
- Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanomaCancer Cell, 2021
- Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy ResistanceCancer Cell, 2020
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressCancer Cell, 2018
- Genomic Classification of Cutaneous MelanomaCell, 2015
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK SignalingCancer Cell, 2015
- Measurement of cell traction forces with ImageJ2015
- Modulation of matrix elasticity with PEG hydrogels to study melanoma drug responsivenessBiomaterials, 2014
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Tensional homeostasis and the malignant phenotypeCancer Cell, 2005
- Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesionCell Motility, 2004